333 related articles for article (PubMed ID: 28317237)
1. Disruption of the Cx43/miR21 pathway leads to osteocyte apoptosis and increased osteoclastogenesis with aging.
Davis HM; Pacheco-Costa R; Atkinson EG; Brun LR; Gortazar AR; Harris J; Hiasa M; Bolarinwa SA; Yoneda T; Ivan M; Bruzzaniti A; Bellido T; Plotkin LI
Aging Cell; 2017 Jun; 16(3):551-563. PubMed ID: 28317237
[TBL] [Abstract][Full Text] [Related]
2. High mobility group box 1 protein regulates osteoclastogenesis through direct actions on osteocytes and osteoclasts in vitro.
Davis HM; Valdez S; Gomez L; Malicky P; White FA; Subler MA; Windle JJ; Bidwell JP; Bruzzaniti A; Plotkin LI
J Cell Biochem; 2019 Oct; 120(10):16741-16749. PubMed ID: 31106449
[TBL] [Abstract][Full Text] [Related]
3. miR‑21 promotes osteoclastogenesis through activation of PI3K/Akt signaling by targeting Pten in RAW264.7 cells.
Wang S; Liu Z; Wang J; Ji X; Yao Z; Wang X
Mol Med Rep; 2020 Mar; 21(3):1125-1132. PubMed ID: 32016444
[TBL] [Abstract][Full Text] [Related]
4. Cell autonomous requirement of connexin 43 for osteocyte survival: consequences for endocortical resorption and periosteal bone formation.
Bivi N; Condon KW; Allen MR; Farlow N; Passeri G; Brun LR; Rhee Y; Bellido T; Plotkin LI
J Bone Miner Res; 2012 Feb; 27(2):374-89. PubMed ID: 22028311
[TBL] [Abstract][Full Text] [Related]
5. Irradiation-induced osteocyte damage promotes HMGB1-mediated osteoclastogenesis in vitro.
He F; Bai J; Wang J; Zhai J; Tong L; Zhu G
J Cell Physiol; 2019 Aug; 234(10):17314-17325. PubMed ID: 30786022
[TBL] [Abstract][Full Text] [Related]
6. Enhanced osteoclastic resorption and responsiveness to mechanical load in gap junction deficient bone.
Zhang Y; Paul EM; Sathyendra V; Davison A; Sharkey N; Bronson S; Srinivasan S; Gross TS; Donahue HJ
PLoS One; 2011; 6(8):e23516. PubMed ID: 21897843
[TBL] [Abstract][Full Text] [Related]
7. miR21 deletion in osteocytes has direct and indirect effects on skeletal muscle in a sex-dimorphic manner in mice.
Essex AL; Deosthale P; Huot JR; Davis HM; Momeni N; Bonetto A; Plotkin LI
Biol Sex Differ; 2022 Oct; 13(1):56. PubMed ID: 36183096
[TBL] [Abstract][Full Text] [Related]
8. Activation of resorption in fatigue-loaded bone involves both apoptosis and active pro-osteoclastogenic signaling by distinct osteocyte populations.
Kennedy OD; Herman BC; Laudier DM; Majeska RJ; Sun HB; Schaffler MB
Bone; 2012 May; 50(5):1115-22. PubMed ID: 22342796
[TBL] [Abstract][Full Text] [Related]
9. Osteocyte Alterations Induce Osteoclastogenesis in an In Vitro Model of Gaucher Disease.
Bondar C; Ormazabal M; Crivaro A; Ferreyra-Compagnucci M; Delpino MV; Rozenfeld PA; Mucci JM
Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28098793
[TBL] [Abstract][Full Text] [Related]
10. Scl-Ab reverts pro-osteoclastogenic signalling and resorption in estrogen deficient osteocytes.
Allison H; Holdsworth G; McNamara LM
BMC Mol Cell Biol; 2020 Nov; 21(1):78. PubMed ID: 33148174
[TBL] [Abstract][Full Text] [Related]
11. Pulsed electromagnetic fields regulate osteocyte apoptosis, RANKL/OPG expression, and its control of osteoclastogenesis depending on the presence of primary cilia.
Wang P; Tang C; Wu J; Yang Y; Yan Z; Liu X; Shao X; Zhai M; Gao J; Liang S; Luo E; Jing D
J Cell Physiol; 2019 Jul; 234(7):10588-10601. PubMed ID: 30422320
[TBL] [Abstract][Full Text] [Related]
12. The role of osteocyte apoptosis in cancer chemotherapy-induced bone loss.
Shandala T; Shen Ng Y; Hopwood B; Yip YC; Foster BK; Xian CJ
J Cell Physiol; 2012 Jul; 227(7):2889-97. PubMed ID: 21938727
[TBL] [Abstract][Full Text] [Related]
13. FOXO1 Mediates Advanced Glycation End Products Induced Mouse Osteocyte-Like MLO-Y4 Cell Apoptosis and Dysfunctions.
Zhang C; Wei W; Chi M; Wan Y; Li X; Qi M; Zhou Y
J Diabetes Res; 2019; 2019():6757428. PubMed ID: 31886284
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of osteocyte apoptosis prevents the increase in osteocytic receptor activator of nuclear factor κB ligand (RANKL) but does not stop bone resorption or the loss of bone induced by unloading.
Plotkin LI; Gortazar AR; Davis HM; Condon KW; Gabilondo H; Maycas M; Allen MR; Bellido T
J Biol Chem; 2015 Jul; 290(31):18934-42. PubMed ID: 26085098
[TBL] [Abstract][Full Text] [Related]
15. Avenanthramides Prevent Osteoblast and Osteocyte Apoptosis and Induce Osteoclast Apoptosis in Vitro in an Nrf2-Independent Manner.
Pellegrini GG; Morales CC; Wallace TC; Plotkin LI; Bellido T
Nutrients; 2016 Jul; 8(7):. PubMed ID: 27409635
[TBL] [Abstract][Full Text] [Related]
16. Sclerostin stimulates osteocyte support of osteoclast activity by a RANKL-dependent pathway.
Wijenayaka AR; Kogawa M; Lim HP; Bonewald LF; Findlay DM; Atkins GJ
PLoS One; 2011; 6(10):e25900. PubMed ID: 21991382
[TBL] [Abstract][Full Text] [Related]
17. Connexin 43 and cell culture substrate differentially regulate OCY454 osteocytic differentiation and signaling to primary bone cells.
Hoppock GA; Buettmann EG; Denisco JA; Goldscheitter GM; Condyles SN; Juhl OJ; Friedman MA; Zhang Y; Donahue HJ
Am J Physiol Cell Physiol; 2023 Oct; 325(4):C907-C920. PubMed ID: 37602413
[TBL] [Abstract][Full Text] [Related]
18. Iron Overload-Induced Osteocyte Apoptosis Stimulates Osteoclast Differentiation Through Increasing Osteocytic RANKL Production In Vitro.
Yang J; Dong D; Luo X; Zhou J; Shang P; Zhang H
Calcif Tissue Int; 2020 Nov; 107(5):499-509. PubMed ID: 32995951
[TBL] [Abstract][Full Text] [Related]
19. Osteocyte network; a negative regulatory system for bone mass augmented by the induction of Rankl in osteoblasts and Sost in osteocytes at unloading.
Moriishi T; Fukuyama R; Ito M; Miyazaki T; Maeno T; Kawai Y; Komori H; Komori T
PLoS One; 2012; 7(6):e40143. PubMed ID: 22768243
[TBL] [Abstract][Full Text] [Related]
20. Osteocytes produce interferon-β as a negative regulator of osteoclastogenesis.
Hayashida C; Ito J; Nakayachi M; Okayasu M; Ohyama Y; Hakeda Y; Sato T
J Biol Chem; 2014 Apr; 289(16):11545-11555. PubMed ID: 24610813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
